Compared with these studies, the current study showed the following noticeable differences: 1) The current study adopted Hb intervals of 1 g/dL, rather than the polycythemia standard, to explore a possible reference Hb level based on the mortality of patients within different Hb intervals. The gene discussed is GSTM1; the disease is polycythemia.